


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-2.07%
-14.56%
-3.10%
-8.34%
ALXO
ALX Oncology Holding
$2.27
ALXO Price Performance
$1.32 (+71.97%)
$1.47 (+54.42%)
$1.26 (+80.16%)
$1 (+127.00%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future
![]()
ALXO Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
ALXO Street Sentiment is extremely bullish and have negative views on the near-term outlook
ALXO has Fair risk level
Risks Indicators

Price under $5

High volatilty

Average key support and resistance price levels
PFE
Pfizer
27.37
-0.76%
GSK
GlaxoSmithKline PLC
60.87
+3.29%
ELVN
Enliven Therapeutics
26.13
-2.21%
AZN
Astrazeneca
209.48
+1.91%
What is ALXO current stock price?
What are ALXO stock strengths?
What is ALXO Risk Level?
What is ALXO market cap and volume?
What is ALXO current Stock IQ?
Should I buy ALXO stock right now?
Is ALXO a Strong Buy right now?
What does a 'Strong Buy' rating mean for ALXO?
What does a 'Strong Sell' rating mean for ALXO?
What factors influence ALXO's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-2.07%
-14.56%
-3.10%
-8.34%
ALXO
ALX Oncology Holding
Current Price
$2.27
Runners Also Watch
PFE
Pfizer
27.37
-0.76%
GSK
GlaxoSmithKline PLC
60.87
+3.29%
ELVN
Enliven Therapeutics
26.13
-2.21%
AZN
Astrazeneca
209.48
+1.91%

ALXO Price Performance
$1.32 (+71.97%)
$1.47 (+54.42%)
$1.26 (+80.16%)
$1 (+127.00%)
ALXO Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future
![]()
ALXO Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
ALXO Street Sentiment is extremely bullish and have negative views on the near-term outlook
ALXO has Fair risk level
Risks Indicators

Price under $5

High volatilty

Average key support and resistance price levels
ALXO Stock IQ
Stock Insights
Not Enough Information
ALXO Latest Analysis
ALX Oncology jumps on venture capital fund share purchase.
Wed Feb 4, 2026
ALX Oncology Prices $150 Mln Offering Of Shares And Pre-funded Warrants . (RTTNews) - ALX Oncology Holdings Inc. (ALXO) a clinical-stage biotechnology company on Friday after the bell announced the pricing of an underwritten offering of 76.98 million shares of common stock at $1.57 per share and pre-funded warrants to purchase 18.57 million shares o
Mon Feb 2, 2026
ALX Oncology announces pricing of underwritten offering. shares up nearly 15%.
Fri Jan 30, 2026
ALX Oncology Announces Pricing of Underwritten Offering. ) a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients'. lives today announced the pricing of an underwritten offering of common stock and pre-funded warrants. ALX Oncology is selling 76979112 shares of common stock and in lieu of common stock to certain investors pre-funded warrants to purchase 18574120 shares of common stock in the offering. The shares of common s
Fri Jan 30, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
ALXO Stock trends
ALXO Stock performance
ALXO Stock analysis
ALXO investment strategies
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.